Australian Clinical Labs slips on alleged consumer law breaches

Australian Clinical Labs

21/04/2026 02:14

** Shares of Australian Clinical Labs ACL.AX fall as much as 2.9% to A$2.03, their worst intraday trading session since March 20

** Stock hits its lowest level since April 16

** The pathology service provider served with a representative proceeding filed in Supreme Court of Victoria

** Claim for customers of Medlab Pathology and/or co prior to July 15, 2022, whose personal information was affected by a cyberattack on Medlab Pathology in February 2022

** Statement of claim to seek damages for affected individuals on basis of alleged breaches of Australian Consumer Law

** Company denies claims, intends to defend itself

** Stock down 25.6% YTD, including the day's moves

 (Reporting by Shivangi Lahiri in Bengaluru)

 ((shivangi.lahiri@thomsonreuters.com))